Fractyl Health (GUTS) announced the appointments of Christopher Thompson, M.D. and Ian Sheffield to its Board of Directors. Christopher Thompson, M.D. is Professor of Medicine at Harvard Medical School and Director of Endoscopy at Brigham and Women’s Hospital, where he also co-leads the Center for Weight Management and Wellness. Ian Sheffield is Managing Partner at North Country Holdings, a private investment firm focused on acquiring and growing U.S.-based businesses. In conjunction with the new director appointments, Amy Schulman has stepped down from the Board of Directors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GUTS:
- Fractyl Health initiated with a Buy at Ladenburg
- Fractyl Health price target lowered to $6 from $12 at Canaccord
- Fractyl Health’s Earnings Call: Strategic Gains Amid Financial Challenges
- Fractyl Health Reports Q2 2025 Financial Results and Progress
- Fractyl Health, Inc.: Promising Developments and Strategic Focus Justify Buy Rating